As a neuro-oncologist, I specialize in treating brain tumors. When I treat a person with a brain tumor, I want to help them and their family make the most of their lives.
Brain tumors represent a convergence of some of the most important questions in science and some of the most challenging situations in life. New research on the molecular mechanisms underlying the development of tumors is opening up opportunities to target those tumors in ways that haven't been explored yet. At the same time, families impacted by brain tumors find themselves in a situation that can be overwhelmingly unfamiliar and difficult. This exciting research and a desire to help these families is why I chose to be a neuro-oncologist.
In my research, we are trying to use new tools to understand the molecular machinery that makes tumors work so we can target those mechanisms specifically with as little risk as possible to the patient.
My own children remind me that life is too important not to have fun and spend time with the people you love. We don't have any trouble filling our "spare" time!
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Multi-institutional analysis of pediatric relapsed/progressive central nervous system germinomas. Clinical Oncology. 2026; 57:104266.
High-dose chemotherapy and re-irradiation associated with improved overall survival in patients with relapsed central nervous system (CNS) non-germinomatous germ cell tumors (NGGCT). Clinical Oncology. 2026; 57:104278.
ID #476 Increased Prevalence of Optic Nerve Hypoplasia in Neurofibromatosis Type 1. Neuro-Oncology Pediatrics. 2026; 2(Supplement_1):wuag026.170.
ID #1028 A Retrospective Review Characterizing the Toxicities, Outcomes, and Molecular Characteristics of Adolescent and Young Adult Patients with Medulloblastoma. Neuro-Oncology Pediatrics. 2026; 2(Supplement_1):wuag026.457.
ID #1002 Hematologic Toxicity during Proton Radiation: a Review of Weekly CBC Results at a Single Center. Neuro-Oncology Pediatrics. 2026; 2(Supplement_1):wuag026.440.
MEK inhibitor-induced dropped head syndrome in pediatrics. Neuro-Oncology Pediatrics. 2026; 2(2):wuag024.
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. Journal of Neuro-Oncology. 2026; 177(3).
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2026; 28(2):535-551.
Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). Clinical Neuropathology. 2026; 45(1):32-35.
Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality. Journal of Neurosurgery: Pediatrics. 2025; 37(2):133-146.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey